| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 90.34× | 90.34× | 108.33× | 83.46× | 88.37× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 3.77× | 3.46× | 4.36× | 4.25× | 4.09× | ||
| 0.59× | 0.59× | 0.47× | 0.59× | 0.41× | ||
| 1.27× | 1.27× | 3.40× | 1.24× | 1.59× | ||
| 0.80× | 0.80× | 1.40× | 0.62× | 0.42× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 88.37 | 83.46 | 108.33 | 90.34 | 90.34 | |
| Working Capital Turnover | 4.09 | 4.25 | 4.36 | 3.46 | 3.77 | |
| Asset Turnover | 0.41 | 0.59 | 0.47 | 0.59 | 0.59 | |
| Cash Conversion (CFO/Net Income) | 1.59 | 1.24 | 3.40 | 1.27 | 1.27 | |
| CFO/EBITDA | 0.42 | 0.62 | 1.40 | 0.80 | 0.80 |